SCHEMBL2481653

SCHEMBL2481653

COC(=O)c1ccc(N2CCN(CCC3=C(c4ccc(Cl)cc4)CC(C)(C)CC3)CC2)cc1Oc1cc2cc[nH]c2cc1F

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 20/20 0.63
BCL2L1 Q07817 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960306 0.95 BCL2 (0.70) BCL2BCL2L1
SCHEMBL1960390 0.91 BCL2 (0.64) BCL2BCL2L1
SCHEMBL1745338 0.88 BCL2 (0.68) BCL2BCL2L1
SCHEMBL1742803 0.88 BCL2 (0.69) BCL2BCL2L1
SCHEMBL1958202 0.87 BCL2 (0.62) BCL2BCL2L1
SCHEMBL1957079 0.86 BCL2 (0.66) BCL2BCL2L1
SCHEMBL1957207 0.86 BCL2 (0.64) BCL2BCL2L1
SCHEMBL1958793 0.85 BCL2 (0.66) BCL2BCL2L1
SCHEMBL1960056 0.84 BCL2 (0.70) BCL2BCL2L1
SCHEMBL1956825 0.84 BCL2 (0.64) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376197-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-10-19 EP disclosed
WO-2010065824-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 WO disclosed